Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 10,846 | 462 | 1,705 | 22,225 | 754 |
| Cost of Goods | N/A | 84 | 69 | 78 | 133 |
| Gross Profit | 10,846 | 378 | 1,636 | 22,147 | 621 |
| Operating Expenses | 15,182 | 14,165 | 13,472 | 16,954 | 20,074 |
| Operating Income | -4,336 | -13,703 | -11,767 | 5,271 | -19,320 |
| Interest Expense | 288 | 393 | 457 | 488 | 534 |
| Other Income | 589 | -174 | 225 | 590 | -81 |
| Pre-tax Income | -4,035 | -14,270 | -11,999 | 5,373 | -19,935 |
| Net Income Continuous | -4,035 | -14,270 | -11,999 | 5,373 | -19,935 |
| Minority Interests | -14 | -4 | -25 | -25 | -107 |
| Net Income | $-4,021 | $-14,266 | $-11,974 | $5,398 | $-19,828 |
| EPS Basic Total Ops | -0.08 | -0.28 | -0.28 | 0.03 | -0.71 |
| EPS Basic Continuous Ops | -0.08 | -0.30 | -0.28 | 0.17 | -0.71 |
| EPS Diluted Total Ops | -0.08 | -0.28 | -0.28 | 0.03 | -0.71 |
| EPS Diluted Continuous Ops | -0.08 | -0.30 | -0.28 | 0.17 | -0.71 |
| EBITDA(a) | $-4,184 | $-13,527 | $-11,608 | $5,460 | $-19,127 |